Skip to main content

Table 1 Characteristics of screened patients

From: Anticoagulant treatment in German family practices – screening results from a cluster randomized controlled trial

Patient characteristics n = 1,761 (%)
Mean age years (SD) 74.6 (10.4)
Sex  
Male 928 (52.7%)
Female 833 (47.3%)
Long-term indication for oral anticoagulation therapy  
Atrial fibrillation/flutter 1,415 (80.4%)
Recurrent venous thromboembolism 142 (8.1%)
Recurrent pulmonary embolism 37 (2.1%)
Mechanical heart prosthesis 93 (5.3%)
Intracardiac thrombus 10 (0.6%)
Other indication 22 (1.2%)
No long-term indication 42 (2.4)
Antithrombotic medication*  
Coumarin 1,554 (88.2%)
Dabigatran 46 (2.6%)
Rivaroxaban 61 (3.5%)
Antiplatelet therapy 55 (3.1%)
Other antithrombotic medication 11 (0.6%)
No antithrombotic medication 34 (2%)
Within therapeutic INR target range** 1,013 (67.3%)
Patient self-management  
INR self-measuring and dose adjustment 149 (8.5%)
INR self-testing and dose adjustment by GP 1 (0.1%)
Patients with migration background 160 (9.1%)
Patients compliance assessed by GP  
Very good compliance 1,157 (65.7%)
Good compliance 450 (25.6%)
Non-compliant 129 (7.3%)
No assessment available 25 (1.4%)
  1. *Apixaban had not been approved at the time of screening.
  2. **INR measurements available for 1,504 patients (89% of patients from category 1 (appropriate OAC treatment) and 3 (over-treatment with oral anticoagulants)).